Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
July 31, 2018
Study Completion Date
August 31, 2018
Conditions
Metastatic Breast Cancer
Trial Locations (1)
28007
Hospital General Universitario Gregorio Marañón, Madrid
All Listed Sponsors
lead
Hospital General Universitario Gregorio Marañon
OTHER
NCT02626039 - Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients | Biotech Hunter | Biotech Hunter